Cargando...
Individualising Anticoagulant Therapy in Atrial Fibrillation Patients
Non-vitamin K antagonist (VKA) oral anticoagulants (NOACs) have emerged as alternatives to VKAs for the prevention of stroke in patients with non-valvular atrial fibrillation. Four NOACS: dabigatran, apixaban, rivaroxaban and edoxaban, have received regulatory approval in Europe from the European Me...
Gardado en:
| Publicado en: | Arrhythm Electrophysiol Rev |
|---|---|
| Autor Principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Radcliffe Cardiology
2016
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5013151/ https://ncbi.nlm.nih.gov/pubmed/27617088 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15420/AER.2016.20.3 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|